CD68 antibody | ED1

100% Secure


Mouse anti Rat CD68:Alexa Fluor® 488

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Mouse anti Rat CD68:Alexa Fluor® 647

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Mouse anti Rat CD68:Biotin

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Mouse anti Rat CD68:FITC

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Mouse anti Rat CD68

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Mouse anti Rat CD68:RPE

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Mouse anti Rat CD68:Alexa Fluor® 700

Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen. The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat.

Product Type
Monoclonal Antibody
Clone
ED1
Isotype
IgG1
Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
MCA341A488 F* 100 Tests
MCA341A647 F* 100 Tests/1ml
MCA341B C 100 Tests
MCA341F F* 0.1 mg
MCA341GA C F* IF IP P* 0.1 mg
MCA341R C F* IF IP P* R WB 0.25 mg
MCA341PE F* 100 Tests
MCA341A700 F* 100 Tests/1ml
Mouse anti rat CD68, clone ED1 recognizes the rat ED1 antigen, a heavily glycosylated protein of ~90 -110 KDa, also known as rat CD68 (Dijkstra et al. 1985).

The ED1 antigen is expressed on most macrophages populations, as well as on monocytes and is considered as a pan-macrophage marker in the rat (Damoiseaux et al. 1994). ED1 is expressed predominantly on the lysosomal membrane and lightly on the cell surface (Dijkstra et al. 1985).

The expression of ED1 antigen being predominantly cytoplasmic (Dijkstra et al. 1985), flow cytometry results are improved by the use of a membrane permeabilization procedure, such as Leucoperm, prior to staining.

Product Details

Target Species
Rat
Species Cross-Reactivity
Target SpeciesCross Reactivity
Bovine
Horse
N.B. Antibody reactivity and working conditions may vary between species.
Product Form
Purified IgG conjugated to Alexa Fluor® 488 - liquid
Product Form
Purified IgG conjugated to Alexa Fluor® 647 - liquid
Product Form
Purified IgG conjugated to Biotin - liquid
Product Form
Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid
Product Form
Purified IgG - liquid
Product Form
Purified IgG conjugated to R. Phycoerythrin (RPE) - lyophilized
Product Form
Purified IgG conjugated to Alexa Fluor® 700 - liquid
Reconstitution
Reconstitute with 1 ml distilled water
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline.
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
Pack Size: 0.1 mg
0.09%Sodium Azide
Pack Size: 0.25 mg
0.09% sodium azide.
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Preservative Stabilisers
0.09%Sodium Azide
1%Bovine Serum Albumin
Carrier Free
Yes
Immunogen
Rat spleen cells
Approx. Protein Concentrations
IgG concentration 0.05 mg/ml
Approx. Protein Concentrations
IgG concentration 0.05 mg/ml
Approx. Protein Concentrations
IgG concentration 0.1 mg/ml
Approx. Protein Concentrations
IgG concentration 0.1 mg/ml
Approx. Protein Concentrations
Pack Size: 0.1 mg
IgG concentration 0.5 mg/ml
Pack Size: 0.25 mg
IgG concentration 1.0 mg/ml
Approx. Protein Concentrations
IgG concentration 0.05 mg/ml
Fusion Partners
Spleen cells from immunised BALB/c mice were fused with cells of the SP2/0-Ag14 mouse myeloma cell line.

Storage Information

Storage
Store at +4oC or at -20oC if preferred.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.

Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
Store at +4oC or at -20oC if preferred.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.

Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
Store at +4oC or at -20oC if preferred.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
Store at +4oC or at -20oC if preferred.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.

Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
Store at +4oC or at -20oC if preferred.

This product should be stored undiluted.

Storage in frost free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
Prior to reconstitution store at +4oC. Following reconstitution store at +4oC.

This product should be stored undiluted.

DO NOT FREEZE. This product is photosensitive and should be protected from light. Should this product contain a precipitate we recommend microcentrifugation before use.
Storage
Store at +4oC or at -20oC if preferred.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.

Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life
18 months from date of despatch.
Shelf Life
18 months from date of despatch.
Shelf Life
18 months from date of despatch.
Shelf Life
18 months from date of despatch.
Shelf Life
18 months from date of despatch.
Shelf Life
12 months from date of reconstitution.
Shelf Life
18 months from date of despatch.

More Information

UniProt
Q4FZY1 Related reagents
Acknowledgements
This product is provided under an intellectual property licence from Life Technologies Corporation. The transfer of this product is contingent on the buyer using the purchase product solely in research, excluding contract research or any fee for service research, and the buyer must not sell or otherwise transfer this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; (c) manufacturing or quality assurance or quality control, or (d) resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad CA 92008 USA or outlicensing@thermofisher.com
Acknowledgements
This product is provided under an intellectual property licence from Life Technologies Corporation. The transfer of this product is contingent on the buyer using the purchase product solely in research, excluding contract research or any fee for service research, and the buyer must not sell or otherwise transfer this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; (c) manufacturing or quality assurance or quality control, or (d) resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad CA 92008 USA or outlicensing@thermofisher.com
Acknowledgements
This product is provided under an intellectual property licence from Life Technologies Corporation. The transfer of this product is contingent on the buyer using the purchase product solely in research, excluding contract research or any fee for service research, and the buyer must not sell or otherwise transfer this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; (c) manufacturing or quality assurance or quality control, or (d) resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad CA 92008 USA or outlicensing@thermofisher.com
Regulatory
For research purposes only

Applications of CD68 antibody

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
Flow Cytometry 1 Neat
Flow Cytometry 1 Neat
Immunohistology - Frozen 1/10
Flow Cytometry 1 Neat
Flow Cytometry 1 1/50 1/100
Immunofluorescence
Immunohistology - Frozen
Immunohistology - Paraffin 2 1/100
Immunoprecipitation
Radioimmunoassays
Western Blotting
Flow Cytometry 1 Neat 1/10
Flow Cytometry 1 Neat
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  2. 2 This product requires protein digestion pre-treatment of paraffin sections e.g. trypsin or pronase
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
  1. 1 Membrane permeabilisation is required for this application. Bio-Rad recommends the use of Leucoperm™ (Product Code BUF09) for this purpose.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive control.antibodies.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive control.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Flow Cytometry
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.
Flow Cytometry
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.

Secondary Antibodies Available

Description Product Code Pack Size Applications List Price Quantity
Human anti Mouse IgG1:HRP HCA036P 0.1 mg E
Goat anti Mouse IgG (H/L):Alk. Phos. (Multi Species Adsorbed) STAR117A 0.5 mg E WB
Goat anti Mouse IgG (H/L):DyLight®488 (Multi Species Adsorbed) STAR117D488GA 0.1 mg F IF
Goat anti Mouse IgG (H/L):DyLight®549 (Multi Species Adsorbed) STAR117D549GA 0.1 mg F IF WB
Goat anti Mouse IgG (H/L):DyLight®649 (Multi Species Adsorbed) STAR117D649GA 0.1 mg F IF
Goat anti Mouse IgG (H/L):DyLight®680 (Multi Species Adsorbed) STAR117D680GA 0.1 mg F WB
Goat anti Mouse IgG (H/L):DyLight®800 (Multi Species Adsorbed) STAR117D800GA 0.1 mg F IF WB
Goat anti Mouse IgG (H/L):FITC (Multi Species Adsorbed) STAR117F 0.5 mg F
Goat anti Mouse IgG (H/L):HRP (Multi Species Adsorbed) STAR117P 0.5 mg E WB
Goat anti Mouse IgG (Fc):FITC STAR120F 1 mg C F
Goat anti Mouse IgG (Fc):HRP STAR120P 1 mg E WB
Rabbit F(ab')2 anti Mouse IgG:RPE STAR12A 1 ml F
Rabbit F(ab')2 anti Mouse IgG:HRP (Human Adsorbed) STAR13B 1 mg C E P RE WB
Goat anti Mouse IgG:FITC (Rat Adsorbed) STAR70 0.5 mg F
Goat anti Mouse IgG:RPE (Rat Adsorbed) STAR76 1 ml F
Goat anti Mouse IgG:HRP (Rat Adsorbed) STAR77 0.5 mg C E P
Goat anti Mouse IgG/A/M:Alk. Phos. STAR87A 1 mg C E WB
Goat anti Mouse IgG/A/M:HRP (Human Adsorbed) STAR87P 1 mg E
Rabbit F(ab')2 anti Mouse IgG:Dylight®800 STAR8D800GA 0.1 mg F IF WB
Rabbit F(ab')2 anti Mouse IgG:FITC STAR9B 1 mg F

Negative Isotype Controls Available

Description Product Code Pack Size Applications List Price Quantity
Mouse IgG1 Negative Control:Alexa Fluor® 488 MCA1209A488 100 Tests/1ml F
Mouse IgG1 Negative Control:Alexa Fluor® 647 MCA1209A647 100 Tests/1ml F
Mouse IgG1 Negative Control:FITC MCA1209F 0.1 mg F
Mouse IgG1 Negative Control MCA1209 0.1 mg F
Mouse IgG1 Negative Control:RPE MCA1209PE 100 Tests F
Mouse IgG1 Negative Control:Alexa Fluor® 700 MCA1209A700 100 Tests/1ml F

Application Based External Images

Flow Cytometry

Immunofluorescence

Immunohistology - Frozen

Immunohistology - Paraffin

Western Blotting

Product Specific References

Source Reference

  1. Dijkstra, C.D. et al. (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.
    Immunology. 54 (3): 589-99.

References for CD68 antibody

  1. Damoiseaux, J.G. et al. (1994) Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1.
    Immunology. 83 (1): 140-7.
  2. Bauer, J. et al. (1994) Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis.
    J Neurosci Res. 38 (4): 365-75.
  3. Bao, F. et al. (2004) Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats.
    J Neurochem. 88 (6): 1335-44.
  4. Zilka, N. et al. (2009) Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy.
    J. Neuroimmunol. 209: 16-25.
  5. Fujita, E. et al. (2010) Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages.
    Am J Pathol. 177 (3): 1143-54.
  6. Salegio, E.A. et al. (2011) Macrophage presence is essential for the regeneration of ascending afferent fibres following a conditioning sciatic nerve lesion in adult rats.
    BMC Neurosci. 12: 11.
  7. Wei, X. et al. (2014) Dural fibroblasts play a potential role in headache pathophysiology.
    Pain. 155: 1238-44.
  8. Naito, Y. et al. (2011) Dietary iron restriction prevents hypertensive cardiovascular remodeling in dahl salt-sensitive rats.
    Hypertension. 57: 497-504.
  9. Baker, S.C. et al. (2011) Cellular integration and vascularisation promoted by a resorbable, particulate-leached, cross-linked poly(ε-caprolactone) scaffold.
    Macromol Biosci. 11 (5): 618-27.
  10. Bedi, A. et al. (2010) Effect of early and delayed mechanical loading on tendon-to-bone healing after anterior cruciate ligament reconstruction.
    J Bone Joint Surg Am. 92: 2387-401.
  11. Liew, H.K. et al. (2012) Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats.
    J Neuroinflammation. 9: 13.
  12. Chiu, T.L. et al. (2012) The treatment of glioblastoma multiforme through activation of microglia and TRAIL induced by rAAV2-mediated IL-12 in a syngeneic rat model.
    J Biomed Sci. 19: 45.
  13. Glorie, L.L. et al. (2012) DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
    Am J Physiol Renal Physiol. 303: F681-8.
  14. Quan, L.D. et al. (2010) Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy.
    Arthritis Res Ther.12: R170.
  15. Peng, J.H. et al. (2012) Effects of Puerariae Radix Extract on Endotoxin Receptors and TNF-α Expression Induced by Gut-Derived Endotoxin in Chronic Alcoholic Liver Injury.
    Evid Based Complement Alternat Med. 2012: 234987.
  16. Matsuda, K. et al. (2010) Hemophagocytic histiocytic sarcoma in a Japanese black cow.
    Vet Pathol. 47: 339-42.
  17. Tian, Y.F. et al. (2013) Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats.
    World J Gastroenterol. 19 (18): 2761-71.
  18. Xiang, Y. et al. (2013) L-carnitine protects against cyclosporine-induced pancreatic and renal injury in rats.
    Transplant Proc. 45 (8): 3127-34.
  19. Wang-Rosenke, Y. et al. (2013) Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat.
    BMC Nephrol. 14: 223.
  20. Dort, J. et al. (2013) Beneficial Effects of Cod Protein on Inflammatory Cell Accumulation in Rat Skeletal Muscle after Injury Are Driven by Its High Levels of Arginine, Glycine, Taurine and Lysine.
    PLoS One. 8: e77274.
  21. Machelska, H. et al. (2004) Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain.
    Br J Pharmacol. 142 (4): 772-80.
  22. Chang, C.Y. et al. (2013) Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats.
    J Nutr Biochem. 24 (12): 2127-37.
  23. Sakuraya, K. et al. (2014) The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
    J Urol. 191 (4): 1139-46.
  24. Xu, X. et al. (2014) Aging aggravates long-term renal ischemia-reperfusion injury in a rat model.
    J Surg Res. 187 (1): 289-96.
  25. Kim, Y.H. et al. (2014) Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels.
    Biomaterials. 35 (1): 214-24.
  26. Lin, Y.C. et al. (2015) Time-course effect of electrical stimulation on nerve regeneration of diabetic rats.
    PLoS One. 10: e0116711.
  27. Matsuda, K. et al. (2009) Two cases of bovine sarcoma in clinically long-standing lesions.
    J Vet Med Sci. 71 (2): 221-4.
  28. Thieme, K. & Oliveira-Souza, M. (2015) Renal Hemodynamic and Morphological Changes after 7 and 28 Days of Leptin Treatment: The Participation of Angiotensin II via the AT1 Receptor.
    PLoS One. 10 (3): e0122265.
  29. Ayoub, M.A. et al. (2015) Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease.
    PLoS One. 10 (3): e0119803.
  30. Bijarnia, R.K. et al. (2015) Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats.
    PLoS One. 10 (4): e0124881.
  31. Oboshi, M. et al. (2015) Temporary dietary iron restriction affects the process of thrombus resolution in a rat model of deep vein thrombosis.
    PLoS One. 10 (5): e0126611.
  32. Nagai, H. et al. (2015) Pulmonary Macrophages Attenuate Hypoxic Pulmonary Vasoconstriction via β3AR/iNOS Pathway in Rats Exposed to Chronic Intermittent Hypoxia.
    PLoS One. 10 (7): e0131923.
  33. Adamo, H.H. et al. (2015) Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.
    PLoS One. 10 (11): e0141601.
  34. Paulsen, I.M.S. et al. (2015) A single simple procedure for dewaxing, hydration and heat-induced epitope retrieval (HIER) for immunohistochemistry in formalin fixed paraffin-embedded tissue.
    European Journal of Histochemistry. 59 (4): 2532-9.
  35. Ibarra, V. et al. (2016) Evaluation of the Tissue Response to Alginate Encapsulated Islets in an Omentum Pouch Model.
    J Biomed Mater Res A. May 3. [Epub ahead of print]
  36. Zeka, B. et al. (2016) Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.
    Acta Neuropathol Commun. 4 (1): 82.
  37. Xu K et al. (2016) Expression of aryl hydrocarbon receptor in rat brain lesions following traumatic brain injury.
    Diagn Pathol. 11 (1): 72.
  38. Gällentoft, L. et al. (2016) Impact of degradable nanowires on long-term brain tissue responses.
    J Nanobiotechnology. 14 (1): 64.
  39. Cóndor JM et al. (2016) Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Stem Cells Transl Med. 5 (8): 1048-57.
  40. Herold, S. et al. (2016) CatWalk gait analysis in a rat model of multiple sclerosis.
    BMC Neurosci. 17 (1): 78.
  41. Szmydynger-Chodobska, J. et al. (2016) The Involvement of Pial Microvessels in Leukocyte Invasion after Mild Traumatic Brain Injury.
    PLoS One. 11 (12): e0167677.
  42. Hashmat, S. et al. (2016) Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.
    Am J Physiol Renal Physiol. 311 (3): F555-61.
  43. Cha, S.J. et al. (2016) Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion.
    J Exp Med. 213 (10): 2099-112.
  44. Murata, M. et al. (2016) Surfactant protein D is a useful biomarker for monitoring acute lung injury in rats.
    Exp Lung Res. 42 (6): 314-21.
  45. Faleiros, C.M. et al. (2016) Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex.
    Life Sci. pii: S0024-3205(16)30665-8. [Epub ahead of print]
  46. Haba, D. et al. (2017) Morphological study on the pressure ulcer-like dermal lesions formed in the rat heel skin after transection of the sciatic nerves.
    Acta Histochem. 119 (1): 39-47.
  47. Landeck, N. et al. (2016) Toxic effects of human and rodent variants of alpha-synuclein in vivo.
    Eur J Neurosci. Nov 28. [Epub ahead of print]
  48. Carrillo-de Sauvage MA et al. (2015) The neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in vivo multimodal magnetic resonance imaging study.
    J Cereb Blood Flow Metab. 35 (6): 917-21.
  49. Chang, C.Y. et al. (2015) Tetramethylpyrazine inhibits neutrophil activation following permanent cerebral ischemia in rats.
    Biochem Biophys Res Commun. 463 (3): 421-7.
  50. Londono, R. et al. (2017) The Effect of Cell Debris within Biologic Scaffolds upon the Macrophage Response.
    J Biomed Mater Res A. Mar 6. [Epub ahead of print]
  51. Xue, Y. et al. (2017) Hydroxyapatite nanoparticle-induced mitochondrial energy metabolism impairment in liver cells: in vitro and in vivo studies.
    J Appl Toxicol. Mar 6. [Epub ahead of print]
  52. Wang, M. et al. (2017) Characterization of the Micro-Environment of the Testis that Shapes the Phenotype and Function of Testicular Macrophages.
    J Immunol. May 1. pii: 1700162. [Epub ahead of print]
  53. Menzies, R.I. et al. (2015) Inhibition of the purinergic P2X7 receptor improves renal perfusion in angiotensin-II-infused rats.
    Kidney Int. 88 (5): 1079-87.
  54. Aarts, S.A.B.M. et al. (2017) Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.
    J Neuroinflammation. 14 (1): 105.
  55. Han, T.T. et al. (2015) Adipose-derived stromal cells mediate in vivo adipogenesis, angiogenesis and inflammation in decellularized adipose tissue bioscaffolds.
    Biomaterials. 72: 125-37.
  56. Kanamori, H. et al. (2017) Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 12 (6): e0180475.
  57. Kühne, L. et al. (2017) Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.
    BMC Immunol. 18 (1): 52.
CiteAb logo - trusted, tested, published

Our CD68 (ED1) Antibody has been referenced in >400 publications*


*Based on February 2018 data from CiteAb's antibody search engine.

Image gallery


New interactive tool: immune cell and marker protein facts at your fingertips

All you need to know about immune cells, lineage, marker expression and the marker protein itself. Providing a direct link to antibodies available to your chosen marker.